Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Segregation of Approved, Rejected, and Quarantined Raw Materials – V 2.0

Posted on By

SOP for Segregation of Approved, Rejected, and Quarantined Raw Materials – V 2.0

Standard Operating Procedure for Segregation of Approved, Rejected, and Quarantined Raw Materials

Department Warehouse / Quality Assurance
SOP No. SOP/RM/103/2025
Supersedes SOP/RM/103/2022
Page No. Page 1 of 15
Issue Date 03/02/2025
Effective Date 07/02/2025
Review Date 03/02/2026

1. Purpose

This Standard Operating Procedure (SOP) outlines the process for segregating approved, rejected, and quarantined raw materials in the warehouse to prevent cross-contamination, ensure material integrity, and maintain compliance with Good Manufacturing Practices (GMP).

2. Scope

This SOP applies to all raw materials stored in the warehouse, including Active Pharmaceutical Ingredients (APIs), excipients, solvents, and other chemicals. It covers procedures for physical segregation, labeling, documentation, and handling of different material statuses.

3. Responsibilities

  • Warehouse Personnel: Ensure proper segregation, labeling, and storage of approved, rejected, and quarantined raw materials. Maintain accurate records of material status.
  • Quality Assurance (QA): Oversee segregation practices, verify compliance with GMP guidelines, and conduct periodic audits.
  • Warehouse Manager: Ensure staff adherence to segregation procedures and address any discrepancies.

4. Accountability

The Warehouse Manager is accountable for implementing and maintaining segregation practices. The QA Manager is responsible for verifying compliance with GMP requirements through audits and documentation reviews.

See also  SOP for Storage of Hygroscopic Raw Materials with Desiccants - V 2.0

5. Procedure

5.1 Material Status Classification

  1. Approved Materials:
    • Materials that have passed quality control testing and are cleared for use in production.
    • Labeled with green tags indicating “APPROVED.”
  2. Quarantined Materials:
    • Materials awaiting quality control testing or under investigation.
    • Labeled with yellow tags indicating “QUARANTINE.”
  3. Rejected Materials:
    • Materials that have failed quality control testing or do not meet specifications.
    • Labeled with red tags indicating “REJECTED.”

5.2 Segregation of Materials

  1. Physical Segregation:
    • Store approved, quarantined, and rejected materials in clearly marked, physically separated areas within the warehouse.
    • Use barriers, color-coded floor markings, or dedicated rooms to prevent mix-ups.
  2. Environmental Controls:
    • Ensure that segregated areas maintain appropriate temperature, humidity, and other environmental conditions as required.
    • Document environmental conditions in the Storage Conditions Log (Annexure-1).

5.3 Labeling and Documentation

  1. Labeling Requirements:
    • All materials must be clearly labeled with:
      • Material Name
      • Batch Number
      • Status (Approved, Quarantine, Rejected)
      • Storage Conditions (if applicable)
    • Document labeling activities in the Labeling Log (Annexure-2).
  2. Status Change Documentation:
    • Any change in material status (e.g., from Quarantine to Approved) must be documented in the Status Change Log (Annexure-3).
    • QA approval is required for all status changes.

See also  SOP for Receiving and Handling Temperature-Sensitive Pharmaceutical Raw Materials - V 2.0

5.4 Handling of Rejected Materials

  1. Storage of Rejected Materials:
    • Store rejected materials in a separate, secure area labeled “REJECTED MATERIALS.”
    • Ensure rejected materials are not accessible for production use.
  2. Disposal of Rejected Materials:
    • Coordinate with QA and Environmental Health & Safety (EHS) teams for proper disposal of rejected materials.
    • Document disposal activities in the Rejected Material Disposal Log (Annexure-4).

5.5 Periodic Review and Compliance Monitoring

  1. Warehouse Inspections:
    • Conduct regular inspections to ensure proper segregation and labeling of materials.
    • Record inspection findings in the Warehouse Inspection Log (Annexure-5).
  2. QA Compliance Audits:
    • QA will conduct periodic audits to verify compliance with segregation procedures.
    • Document audit findings in the Compliance Audit Log (Annexure-6).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practice
  • QA: Quality Assurance
  • EHS: Environmental Health & Safety

7. Documents

  1. Storage Conditions Log (Annexure-1)
  2. Labeling Log (Annexure-2)
  3. Status Change Log (Annexure-3)
  4. Rejected Material Disposal Log (Annexure-4)
  5. Warehouse Inspection Log (Annexure-5)
  6. Compliance Audit Log (Annexure-6)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals
  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • WHO GMP Guidelines

9. SOP Version

Version: 2.0

See also  SOP for Storage of Non-Pharmacopoeial Grade Raw Materials - V 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Storage Conditions Log

Date Storage Area Temperature (°C) Humidity (%) Recorded By
03/02/2025 Approved Materials Area 22°C 45% Ravi Kumar

Annexure-2: Labeling Log

Date Material Name Batch Number Status Labeled By
03/02/2025 API-X API-X-2025-001 Approved Sunita Sharma

Annexure-3: Status Change Log

Date Material Name Batch Number Previous Status New Status Approved By
04/02/2025 Excipent-Y EX-Y-2024-002 Quarantine Approved Anjali Mehta

Annexure-4: Rejected Material Disposal Log

Date Material Name Batch Number Disposal Method Disposed By
05/02/2025 API-Y API-Y-2025-003 Incineration Ravi Kumar

Annexure-5: Warehouse Inspection Log

Date Area Inspected Inspector Findings Corrective Actions
06/02/2025 Quarantine Area Anjali Mehta No issues found N/A

Annexure-6: Compliance Audit Log

Date Audit Type Findings Corrective Actions Audited By
07/02/2025 Segregation Compliance Audit All procedures compliant N/A Anjali Mehta

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
03/02/2025 2.0 Updated Segregation Procedures and Documentation Formats Regulatory Compliance QA Head
Raw Material Warehouse V 2.0 Tags:Audit compliance in material storage, Contamination prevention in warehouses, Documentation in warehouse operations, Emergency procedures in warehouses, Equipment maintenance in warehouses, FIFO method in inventory, Handling of hazardous materials, Inventory management SOP, Labeling requirements in warehouses, Loading and unloading procedures, Material inspection protocol, Material receiving process, Material segregation guidelines, Pest control in storage areas, Quality control in warehousing, Raw material handling SOP, Return material handling SOP, Safety procedures for material handling, Security measures for stored materials, Spill response procedures, Storage conditions for raw materials, Temperature and humidity control in storage, Training for warehouse personnel, Warehouse storage procedures, Waste management in warehouses

Post navigation

Previous Post: Ointments: SOP for Visual Inspection After Cleaning – V 2.0
Next Post: Capsule: SOP for Selecting Plasticizers for Soft Gelatin Capsule Shells – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version